Arrayit Licenses Microarrays, Reagents to Belmedtechnika

Jan 16, 2009

NEW YORK (GenomeWeb News) — Arrayit has licensed its microarray platform and associated reagents to Belmedtechnika, an equipment provider in Belarus, Arrayit said yesterday.

Arrayit, a subsidiary of Integrated Media Holdings, said that Belmedtechnika will deploy its high-throughput genotyping platform to screen and test number patient samples "quickly, affordably, and accurately."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Mice With Same-Sex Parents Born

Researchers in China have generated mouse pups from same-sex parents, according to Scientific American.

Hong Kong's Research Funding Boost

The South China Morning Post reports that Hong Kong plans to add HK$20 billion (US$2.6 billion) to a research endowment.

Don't Touch

Two research teams find a role for PIEZO2 in touch sensitivity after injury and inflammation.

This Week in Science

In Science this week: open genetic genealogy databases can lead to the identification of individuals who have not sought testing, and more.

Featured White Papers

Tissue Section Imaging

In Vivo Validation of Optical Probes

Ex Vivo Imaging Quick Start Guide

Probe Design and In Vitro Validation Quick Start Guide

Oct

17

Featured Webinar

Reliable RNA-Seq Expression Profiling from Low-Quality FFPE Biobank Samples

This webinar will present a method for RNA-seq expression analysis of FFPE-derived RNA samples that are too degraded for successful application of standard RNA-seq techniques.

Oct

25

Featured Webinar

A Comprehensive Strategy for Evaluating NGS Liquid Biopsy and Tumor Tissue Assays

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate NGS oncology assays for genomic tumor profiling of plasma and tissue samples.

Main menu